FNH of the liver is not a contraindication to the use of Gynoflor.

Short-term use of Gynoflor should not pose a risk. According to the study, "Women taking oral contraceptives or other hormonal preparations are usually offered to discontinue them, although their effect on the development of FNH has not been confirmed."

Since, according to the manufacturer, Gynoflor has a topical effect (Thanks to the low dose of estriol (0.03 mg), topical administration of the product and the limited length of
treatment (6-12 days) there is no accumulation of estriol and systemic estrogenic effects are very unlikely.) - Knowing the mechanism of action of the drug, it does not appear to have any effect on the diagnosed liver change.

Here you can check the availability of the medicine and make a reservation at the pharmacy of your choice:

https://www.gdziepolek.pl/produkty/34086/gynoflor-tabletki-dopochwowe/apteki